Detection of Chemotherapy Induced Cardiotoxicity
NCT00636844 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 36
Last updated 2013-03-13
Summary
To identify patients that are at risk of heart damage after receiving chemotherapy (adriamycin).
Conditions
Sponsors & Collaborators
-
George Washington University
lead OTHER
Principal Investigators
-
Jannet Lewis, MD · George Washington University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-01-31
- Primary Completion
- 2011-12-31
- Completion
- 2012-06-30
Countries
- United States
Study Locations
More Related Trials
-
Prevention and Pharmacological Management of Cardiac Adverse Drug Reactions Induced by Drugs Used in Oncology.
NCT03678337 ·Status: UNKNOWN
-
Ivabradine to Prevent Anthracycline-induced Cardiotoxicity
NCT04030546 ·Status: UNKNOWN ·Phase: PHASE3
-
Cardioprotection on Chemotherapy-Induced Cardiotoxicity
NCT06853951 ·Status: RECRUITING ·Phase: PHASE3
-
Assessment of Myocardial Injury in Patients Treated With Immune Checkpoint Inhibitors
NCT05349058 ·Status: UNKNOWN
-
JOint Use of Database to Identify Risk Factors of CARDio-vascular Toxicity Induced by Immune Checkpoint Inhibitors
NCT04294771 ·Status: UNKNOWN
-
Dapagliflozin to Prevent Anthracycline-Induced Cardiotoxicity
NCT06888505 ·Status: COMPLETED ·Phase: PHASE2
-
Ivabradine to Prevent Anthracycline-induced Cardiotoxicity
NCT03650205 ·Status: UNKNOWN ·Phase: NA
-
Assessment of Global Longitudinal Strain for the Prediction of Anthracycline Induced Cardiotoxicity
NCT02875171 ·Status: COMPLETED
-
Evaluation of Reporting of Immune Checkpoint Inhibitor Associated Cardio-vascular Adverse Reactions
NCT03387540 ·Status: COMPLETED
-
Monitoring Drug-induced Myocarditis (CardiTOX)
NCT03855982 ·Status: COMPLETED
-
Risk Analysis of Cardiotoxic Medication Use Due to Sodium Arsenite Chloride Injection
NCT06060132 ·Status: UNKNOWN
-
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
NCT05724121 ·Status: RECRUITING
-
Ivabradine in the Management of Cardiac Autonomic Dysfunction Associated With Thoracic Radiation Therapy.
NCT03137537 ·Status: TERMINATED ·Phase: PHASE2
-
Myocardial Fibrosis Identification in Patients With Anthracycline-induced Cardiotoxicity
NCT06331806 ·Status: RECRUITING ·Phase: NA
-
Desflurane-induced Myocardial Protection
NCT02019797 ·Status: UNKNOWN ·Phase: PHASE4
-
Effectiveness of Oral Anticoagulants in Elderly Patients With Non-Valvular Atrial Fibrillation and Heart Failure
NCT03508271 ·Status: COMPLETED
-
Laboratory Assessment of the Concentration of Direct Oral Anticoagulants in Patients With Atrial Fibrillation
NCT04684056 ·Status: UNKNOWN
-
Early rhBNP on Myocardial Work in Patients With STEMI
NCT04157868 ·Status: UNKNOWN ·Phase: PHASE4
-
Daptomycin Concentration in Drainage Fluid and Blood Samples of ICU Patients
NCT03004066 ·Status: COMPLETED
-
Adrecizumab in Cardiogenic Shock
NCT03989531 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Carcinoid Heart Disease and Peptide Receptor Radiotargetted Therapy
NCT04039516 ·Status: UNKNOWN ·Phase: PHASE2
-
Innovative Biomarkers of Cardiovascular Complications Associated With Second-generation Bruton Tyrosine Kinase Inhibitor Treatments: a Single-center Cohort Study
NCT07174141 ·Status: RECRUITING
-
SGLT2i As Anti Arrhythmic Therapy to Prevent Sudden Cardiac Deaths.
NCT03366181 ·Status: COMPLETED
-
Empagliflozin in the Prevention of Cardiotoxicity in Cancer Patients Undergoing Chemotherapy Based on Anthracyclines
NCT05271162 ·Status: RECRUITING ·Phase: PHASE3
-
Oral Nicorandil in ST Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention
NCT04632121 ·Status: UNKNOWN